Acute/baseline ratios of all 3 MC mediator metabolites can enhance diagnosis and management of mast cell activation syndrome

This publication has 18 references indexed in Scilit:

• A US-Based Multicenter Retrospective Report of Perioperative Anaphylaxis, 2010-2021
  The Journal of Allergy and Clinical Immunology: In Practice, 2024
• Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome
  The Journal of Allergy and Clinical Immunology: In Practice, 2023
• Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis
  Journal of Allergy and Clinical Immunology, 2022
• The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
  The Journal of Allergy and Clinical Immunology: In Practice, 2020
• Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction
  The Journal of Allergy and Clinical Immunology: In Practice, 2019
• Effect of IL-33 on de novo synthesized mediators from human mast cells
  Journal of Allergy and Clinical Immunology, 2019
• Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis
  Immunology and Allergy Clinics of North America, 2018
• Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease
  Journal of Allergy and Clinical Immunology, 2016
• Mast Cell Activation Syndrome: Improved Identification by Combined Determinations of Serum Tryptase and 24-Hour Urine 11β-Prostaglandin2α
  The Journal of Allergy and Clinical Immunology: In Practice, 2014
• Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.
  Proceedings of the National Academy of Sciences, 1983